Recruiting
Phase 2

Dupilumab in the Treatment of Pediatric Alopecia Areata

Sponsor:

Icahn School of Medicine at Mount Sinai

Code:

NCT05866562

Conditions

Alopecia Areata

Eligibility Criteria

Sex: All

Age: 6 - 17

Healthy Volunteers: Not accepted

Interventions

Dupilumab

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information